4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-022901
President and CEO sold 5,628 shares at an average $0.64 ($3,604)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lucchino David L. President and CEO | 2023-08-16 | Sale 10b5-1 | −2,895 | $0.65 | $1,882 | 642,399 | D: show line 1 in the form |
| Lucchino David L. President and CEO | 2023-08-17 | Sale 10b5-1 | −2,733 | $0.63 | $1,722 | 639,666 | D: show line 2 in the form |
| Open-market sales · 5,628 sh · avg $0.64 · $3,604 | |||||||
Loading xslF345X05/form4.xml…